The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study

被引:11
作者
Jil, Mamza [1 ]
Rajnikant, Mehta [2 ]
Richard, Donnelly [1 ]
Iskandar, Idris [1 ]
机构
[1] Univ Nottingham, Royal Derby Hosp, Sch Med, Div Med Sci & Grad Entry Med, Uttoxeter Rd, Derby DE22 3DT, England
[2] Univ Nottingham, Sch Med, Res Design Serv East Midlands, Nottingham, England
关键词
Insulin; gliptins; cardiovascular; intensification; OUTCOMES; GLUCOSE; RISK; ASSOCIATION; SURVIVAL; DISEASE;
D O I
10.1177/1479164116687102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To compare time to a composite endpoint of non-fatal acute myocardial infarction, non-fatal stroke or all-cause mortality in patients with type 2 diabetes mellitus who had their treatment intensified with a dipeptidylpeptidase-4 inhibitor or insulin following dual-therapy (metformin plus sulfonylurea) failure. Methods: A retrospective cohort study was conducted on 5238 patients newly treated with either a dipeptidylpeptidase-4 inhibitor or insulin following dual-therapy failure (2007-2014). Data were sourced from UK General Practices. The risk of the composite outcome was compared between two treatment groups: metformin+sulfonylurea+insulin (n=1584) and metformin+sulfonylurea+dipeptidylpeptidase-4 inhibitor (n=3654), while adjusting for baseline covariates. Follow-up was for up to 5years. Propensity score matching analysis and Cox proportional hazard models were employed. Results: Overall, 123 and 171 composite outcome events occurred among patients who added insulin versus dipeptidylpeptidase-4 inhibitor, respectively (44.5 vs 14.6 events per 1000person-years). Addition of insulin was associated with a significantly higher hazard ratio versus the addition of a dipeptidylpeptidase-4 inhibitor (adjusted hazard ratio=2.6, 95% confidence interval: 1.9-3.4; p<0.01), an effect that was more pronounced in obese (body mass index: 30-34.9kg/m(2)) patients (corresponding adjusted hazard ratio 3.6, 95% confidence interval: 2.3-5.6; p<0.01). Conclusion: In routine clinical practice, intensification of metformin+sulfonylurea therapy by adding insulin is associated with increased risk of cardiovascular events and death compared with adding a dipeptidylpeptidase-4 inhibitor. These findings are in line with suggestions from previous studies regarding the cardiovascular safety of insulin in type 2 diabetes mellitus, but should be interpreted with caution.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 32 条
[1]  
[Anonymous], TYP 2 DIAB NEW AG
[2]  
[Anonymous], 2013, Stata Statistical Software: Release 13
[3]   The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments [J].
Austin, Peter C. .
STATISTICS IN MEDICINE, 2014, 33 (07) :1242-1258
[4]   NEW EVIDENCE ON THE FINITE SAMPLE PROPERTIES OF PROPENSITY SCORE REWEIGHTING AND MATCHING ESTIMATORS [J].
Busso, Matias ;
DiNardo, John ;
McCrary, Justin .
REVIEW OF ECONOMICS AND STATISTICS, 2014, 96 (05) :885-897
[5]   A prospective study of obesity and risk of coronary heart disease among diabetic women [J].
Cho, EY ;
Manson, JE ;
Stampfer, MJ ;
Solomon, CG ;
Colditz, GA ;
Speizer, FE ;
Willett, WC ;
Hu, FB .
DIABETES CARE, 2002, 25 (07) :1142-1148
[6]   Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes [J].
Currie, Craig J. ;
Poole, Chris D. ;
Evans, Marc ;
Peters, John R. ;
Morgan, Christopher Ll .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (02) :668-677
[7]   Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study [J].
Currie, Craig J. ;
Peters, John R. ;
Tynan, Aodan ;
Evans, Marc ;
Heine, Robert J. ;
Bracco, Oswaldo L. ;
Zagar, Tony ;
Poole, Chris D. .
LANCET, 2010, 375 (9713) :481-489
[8]   Insulin use and increased risk of mortality in type 2 diabetes: a cohort study [J].
Gamble, J. -M. ;
Simpson, S. H. ;
Eurich, D. T. ;
Majumdar, S. R. ;
Johnson, J. A. .
DIABETES OBESITY & METABOLISM, 2010, 12 (01) :47-53
[9]  
Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
[10]   Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia [J].
Gerstein, Hertzel C. ;
Bosch, Jackie ;
Dagenais, Gilles R. ;
Diaz, Rafael ;
Jung, Hyejung ;
Maggioni, Aldo P. ;
Pogue, Janice ;
Probstfield, Jeffrey ;
Ramachandran, Ambady ;
Riddle, Matthew C. ;
Ryden, Lars E. ;
Yusuf, Salim .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (04) :319-328